Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory coeliac disease

D. Sánchez, L. Palová-Jelínková, J. Felsberg, M. Šimšová, A. Pekaríková, B. Pecharová, I. Swoboda, T. Mothes, C.J. Mulder, Z. Beneš, H. Tlaskalová-Hogenová, L. Tučková

. 2008 ; 153 (3) : 351-359.

Jazyk angličtina Země Velká Británie

Perzistentní odkaz   https://www.medvik.cz/link/bmc11010035

E-zdroje NLK

Free Medical Journals od 1966 do Před 1 rokem
PubMed Central od 1966 do Před 1 rokem
Medline Complete (EBSCOhost) od 1966-01-01 do Před 1 rokem
Wiley Online Library (archiv) od 1990-01-01 do 2012-12-31

Refractory coeliac disease (RCD) is a very rare and dangerous form of CD, in which gluten-free diet loses its therapeutic effect and the damage of intestinal mucosa persists. Because of the adherence to the diet, serological markers of CD [immunoglobulin A (IgA) antibodies against gliadin, tissue transglutaminase (tTG) and endomysium] are often missing in RCD patients. We found substantially elevated levels of IgA anti-calreticulin (CRT) antibodies in the sera of almost all RCD patients tested. These sera were negative for IgA antibodies to gliadin and tTG and only some of them showed IgA antibodies to enterocytes. Analysis of patients' IgA reactivity to CRT fragments (quarters and halves) by Western blotting revealed differences in the specificity of IgA antibodies between RCD and CD patients. We therefore used the Pepscan technique with synthetic overlapping decapeptides of CRT to characterize antigenic epitopes recognized by serum IgA antibodies of RCD patients. Employing this method we demonstrated several dominant antigenic epitopes recognized by IgA antibodies of RCD patients on the CRT molecule. Epitope GVTKAAEKQMKD was recognized predominantly by serum IgA of RCD patients. Our results suggest that testing for serum IgA antibodies against CRT and its selected peptide could be a very useful tool in RCD differential diagnosis.

000      
03685naa 2200625 a 4500
001      
bmc11010035
003      
CZ-PrNML
005      
20121115111516.0
008      
110512s2008 xxk e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Sánchez, Daniel
245    10
$a Anti-calreticulin immunoglobulin A (IgA) antibodies in refractory coeliac disease / $c D. Sánchez, L. Palová-Jelínková, J. Felsberg, M. Šimšová, A. Pekaríková, B. Pecharová, I. Swoboda, T. Mothes, C.J. Mulder, Z. Beneš, H. Tlaskalová-Hogenová, L. Tučková
314    __
$a Department of Immunology, Institute of Microbiology, Czech Academy of Sciences, Prague, Czech Republic. sanchez.cohn@gmail.com
520    9_
$a Refractory coeliac disease (RCD) is a very rare and dangerous form of CD, in which gluten-free diet loses its therapeutic effect and the damage of intestinal mucosa persists. Because of the adherence to the diet, serological markers of CD [immunoglobulin A (IgA) antibodies against gliadin, tissue transglutaminase (tTG) and endomysium] are often missing in RCD patients. We found substantially elevated levels of IgA anti-calreticulin (CRT) antibodies in the sera of almost all RCD patients tested. These sera were negative for IgA antibodies to gliadin and tTG and only some of them showed IgA antibodies to enterocytes. Analysis of patients' IgA reactivity to CRT fragments (quarters and halves) by Western blotting revealed differences in the specificity of IgA antibodies between RCD and CD patients. We therefore used the Pepscan technique with synthetic overlapping decapeptides of CRT to characterize antigenic epitopes recognized by serum IgA antibodies of RCD patients. Employing this method we demonstrated several dominant antigenic epitopes recognized by IgA antibodies of RCD patients on the CRT molecule. Epitope GVTKAAEKQMKD was recognized predominantly by serum IgA of RCD patients. Our results suggest that testing for serum IgA antibodies against CRT and its selected peptide could be a very useful tool in RCD differential diagnosis.
590    __
$a bohemika - dle Pubmed
650    _2
$a senioři $7 D000368
650    _2
$a protilátky anti-idiotypické $x imunologie $x krev $7 D000888
650    _2
$a western blotting $7 D015153
650    _2
$a kalretikulin $x imunologie $x krev $7 D037282
650    _2
$a celiakie $x diagnóza $x imunologie $x krev $7 D002446
650    _2
$a bezlepková dieta $x škodlivé účinky $7 D055050
650    _2
$a enterocyty $x chemie $x imunologie $7 D020895
650    _2
$a ELISA $7 D004797
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a gliadin $x imunologie $x krev $7 D005903
650    _2
$a lidé $7 D006801
650    _2
$a imunoglobulin A $x imunologie $x krev $7 D007070
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a senzitivita a specificita $7 D012680
650    _2
$a transglutaminasy $x imunologie $x krev $7 D011503
650    _2
$a financování organizované $7 D005381
700    1_
$a Palová, Lenka, $d 1976- $7 mzk2008434074
700    1_
$a Felsberg, Jürgen
700    1_
$a Šimšová, Marcela. $7 xx0222318
700    1_
$a Pekáriková, Aneta $7 xx0141851
700    1_
$a Pecharová, Barbara $7 xx0127962
700    1_
$a Swoboda, I.
700    1_
$a Mothes, T.
700    1_
$a Mulder, C.J.
700    1_
$a Beneš, Zdeněk, $d 1955- $7 xx0039313
700    1_
$a Tlaskalová, Helena, $d 1938- $7 jn20000402365
700    1_
$a Tučková, Ludmila, $d 1945- $7 xx0036257
773    0_
$t Clinical & Experimental Immunology $w MED00009471 $g Roč. 153, č. 3 (2008), s. 351-359
910    __
$a ABA008 $b x $y 2
990    __
$a 20110513102132 $b ABA008
991    __
$a 20121115111533 $b ABA008
999    __
$a ok $b bmc $g 839304 $s 703444
BAS    __
$a 3
BMC    __
$a 2008 $b 153 $c 3 $d 351-359 $m Clinical and experimental immunology $n Clin Exp Immunol $x MED00009471
LZP    __
$a 2011-2B09/jvme